Purpose: Netarsudil is a Rho kinase/norepinephrine transporter inhibitor currently in phase
3 clinical development for glaucoma treatment. We investigated the effects of its active …

This paper proposes a deep image analysis–based model for glaucoma diagnosis that uses
several features to detect the formation of glaucoma in retinal fundus. These features are …

Glaucoma is the dominant reason for irreversible blindness worldwide, and its best remedy
is early and timely detection. Optical coherence tomography has come to be the most …

Purpose: Tyrosine kinase with immunoglobulin-like and EGF-like domains 2 (Tie2)
activation in Schlemm's canal (SC) endothelium is required for the maintenance of IOP …

Introduction: Primary open-angle glaucoma (POAG) is a leading cause for worldwide
blindness and is characterized by progressive optic nerve damage. The etiology of POAG is …

The primary cause of irreversible blindness due to glaucoma is a silent, progressive disease
with no noticeable symptoms. This eye disease gradually and rapidly damages the optic …

Purpose We tested whether dietary modification (DM) altered the risk for incident primary
open-angle glaucoma (POAG). Design Secondary analysis of a randomized intervention …

Glaucoma is a leading cause of permanent vision loss. Early detection and treatment of this
infection is critical for recovery and slowing the progression of vision loss. An efficient novel …

Purpose Previous studies suggest that hormone therapy favorably affects intraocular
pressure (IOP). Here, we examined the association between hormone therapy use and IOP …

Retinal ganglion cells (RGCs), used as a common model of central nervous system injury,
are particularly vulnerable to metabolic and oxidative damage. However, molecular …